Home
  About Us
What We Do

Therapeutic Areas

Related Links

Careers

Contact us
   
 
  India
1) Central Drugs Standard Control
Organization (CDSCO)
2) Indian Council of Medical Research
(ICMR)
3) Department of Biotechnology (DBT)
  International
1) U.S. FDA
2) Center watch
3) International Conference on
Harmonization (ICH)
   
Therapeutic Areas
  Endocrinology/Metabolism | Oncology | Gynecology | Cardiology | Infectious Diseases | Neurology  
  Pain and Rheumatology | Psychiatry | Gastroenterology | Ophthalmology | Dermatology | Medical Devic  
 


Endocrine/Metabolic

Some of the most serious health problems of our time, such as diabetes, obesity, hypertension, osteoporosis, and hormonal disturbances, are endocrine and metabolic related

According to WHO figures, In 1985, there was an estimated 30 million people with diabetes world wide
The 1997 WHO report has shown that there is a marked increase in the number of people affected with diabetes and this trend is scheduled to grow in geometric proportions in the next couple of decades.


YEAR NO OF PEOPLE AFFECTED (in millions)

1995

124.7

2000

153.9

2025

299.1

The number of people with Diabetes is increasing due to population growth, aging, urbanization, and increasing prevalence of obesity and physical inactivity. The total number of diabetes people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030. The prevalence of diabetes is higher in men than women, but there are more women with diabetes than men. The urban population of the developing countries is projected to double between 2000 and 2030. The estimated number of people with diabetes in India in 2000 is 31 million which will increase to 79 million in 2030.

The human and economic costs of this epidemic are enormous. Mortality from communicable diseases and infant and maternal mortality in less-developed countries are declining. In association with increasing diabetes prevalence, this will inevitably result in increasing proportions of deaths from cardiovascular disease in these countries, as well as increased prevalence and associated consequences of other complications of diabetes. A concerted, global initiative is required to address the diabetes epidemic.

 
Copyright © 2009 Arête Clinical Research Consulting Service Inc